Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 14,499 | 20,300 | 21,088 | 17,481 | 18,944 |
| Operating Income | -14,499 | -20,300 | -21,088 | -17,481 | -18,944 |
| Interest Expense | 2,312 | 2,327 | 1,302 | 1,253 | 1,255 |
| Other Income | 4 | 1 | 4 | 19 | 117 |
| Pre-tax Income | -16,807 | -22,626 | -22,386 | -18,715 | -20,082 |
| Net Income Continuous | -16,807 | -22,626 | -22,386 | -18,715 | -20,066 |
| Net Income | $-16,807 | $-22,626 | $-22,386 | $-18,715 | $-20,066 |
| EPS Basic Total Ops | -0.63 | -0.86 | -0.88 | -0.75 | -0.80 |
| EPS Basic Continuous Ops | -0.63 | -0.86 | -0.88 | -0.75 | -0.80 |
| EPS Diluted Total Ops | -0.63 | -0.86 | -0.88 | -0.75 | -0.80 |
| EPS Diluted Continuous Ops | -0.63 | -0.86 | -0.88 | -0.75 | -0.80 |
| EBITDA(a) | $-14,035 | $-20,194 | $-20,986 | $-17,375 | $-18,848 |